Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition - EPOS services

21 Jun 2005 07:00

XN Checkout Holdings PLC21 June 2005 Press Release 21 June 2005 XN Checkout Holdings Plc ("XNC" or "the Company") XN Checkout acquires EpoS Computing Services Ltd (ECS) XN Checkout Holdings Plc (AIM:XNC), a market leader of Electronic Point of Sale("EPOS") solutions to the leisure, retail and hospitality markets, announces theacquisition of EpoS Computing Services Ltd. The consideration for theacquisition is substantially calculated on an earn-out basis on ECS's 2005 and2006 figures, will be satisfied in a mixture of cash and shares, and is notexpected to exceed £4 million. For the year ended 30 September 2004, ECS reported a turnover of £3.2 millionand a gross profit of £1.0 million. It had net assets at this date of £142,000. Following the acquisition, ECS will continue to be managed independently fromXNC. Milton Keynes based ECS is the largest independent EPOS service deliveryprovider in the UK, and has coverage throughout the UK and Europe. ECS managesthe roll out of EPOS systems including installation, managing system changeover, testing and training The acquisition allows XNC to consolidate andstrengthen its EPOS service delivery offering, which has previously been partlyoutsourced to subcontractors. Founded in 1996 by Nigel Friery, ECS operates in both the Hospitality and Retailsectors and provides EPOS services to a large portfolio of high-street namessuch as Asda, BP Oil, Compass Catering, Sainsburys, Tesco, Vodafone andWhitbread Restaurants among others. In addition, and of particular interest toXNC, ECS has significant experience in integrating wireless POS systems withinthe UK Hospitality sector. Commenting on the acquisition, Nigel Friery, Managing Director of ECS, said: "There are many synergies between the two organizations and I look forward tocontinuing in my role of Managing Director of ECS as we continue to exploit theopportunities available with both XN Checkout and other companies." Ed Dayan, Chief Executive of XN Checkout, added: "The knowledge, huge breadthof services and experience of large POS roll outs in the UK brought by ECS willadd immense value to XN Checkout at a time when it is embarking upon a number ofsystem roll-outs to new and existing customers." The Directors would like to draw shareholders' attention to the announcementthat was issued on 10 June 2005 which referred to a Recommended Offer byEvolution Securities Limited on behalf of Torex Retail Plc for the entire sharecapital of XN Checkout Holdings Plc. For further information:XN Checkout Holdings PlcEd Dayan, Chief Executive +44 (0) 1582 869 600edayan@xncheckout.com www.xncheckout.com Daniel Stewart & Co.Ruari McGirr Tel: +44 (0) 20 7374 6789ruari.mcgirr@danielstewart.co.uk www.danielstewart.co.uk Media enquiries:AbchurchAriane Comstive / Henry Harrison-Topham Tel: +44 (0) 20 7398 7700ariane.comstive@abchurch-group.com www.abchurch-group.com Notes to editors XN Checkout Holdings Plc XN Checkout is the market leader for EPOS hardware and software solutions intothe UK managed pub and bar sector, with over 4,000 systems installed. TheCompany has been successful in broadening its target markets to includerestaurants, hotels, retail shops and gaming hardware and software solutions. Co-founded in 1982 by the chief executive Ed Dayan, the Company created thefirst touch-till system for a pub and has over 20 years' experience ofmanufacturing hardware and developing software solutions for the EPOS market,resulting in XN Checkout technology remaining at the forefront of the industry.The Company's technology is now being used in the hotel, gaming, retail and thefast-growing SME hospitality sectors. As an innovator of web-based EPOS systems, XN Checkout benefits fromlong-standing client relationships with leading leisure and hospitalitybusinesses including Mitchells & Butlers, Wolverhampton & Dudley, the SpiritGroup, Young's and Stena Line. More recent customers include Cafe Rouge, TheParamount Group of Hotels, Caffe Nero and Gala Group. The Company employs 190people, is based in Dunstable, Bedfordshire and has offices in Singapore,Malaysia, South Korea, Australia, South Africa, the USA and Germany. For further information please visit www.xncheckout.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Nov 20249:32 amRNSForm 8.3 - Tissue Regenix Group Plc
12th Nov 20244:05 pmRNSForm 8 (OPD) (Tissue Regenix Group Plc)
12th Nov 20248:46 amRNSForm 8.5 (EPT/NON-RI)
11th Nov 20249:17 amRNSForm 8.5 (EPT/NON-RI)
7th Nov 20249:59 amRNSForm 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
6th Nov 20241:37 pmRNSForm 8.3 - Tissue Regenix Group PLC
6th Nov 20248:52 amRNSForm 8.5 (EPT/NON-RI)
5th Nov 20242:24 pmRNSForm 8.3 - Tissue Regenix Group PLC
5th Nov 202411:32 amRNSForm 8.5 (EPT/NON-RI)
4th Nov 20244:36 pmRNSResponse to media speculation
10th Sep 20247:00 amRNSInterim results for the six months ended 30 June
18th Jul 20243:52 pmRNSGrant of share options
16th Jul 20247:00 amRNSHalf-Year Trading Update
3rd Jul 20241:16 pmRNSHolding(s) in Company
24th Jun 20244:12 pmRNSHolding(s) in Company
18th Jun 20245:15 pmRNSExercise of Options, Director Dealing and TVR
14th Jun 20247:00 amRNSBuilding purchase
25th Apr 20242:27 pmRNSResult of AGM
10th Apr 20247:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth
5th Apr 20243:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSFinal results for the year ended 31 December 2023
1st Mar 20247:00 amRNSNotice of Results
6th Feb 20247:00 amRNSFirst EU shipment & new distributor agreements
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading update for 2023
23rd Jan 20245:24 pmRNS2023 LTIP Grant
22nd Nov 20234:36 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSHPRA approval & distribution agreement in Spain
18th Sep 202310:40 amEQSHardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
15th Sep 20234:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:01 amRNSNew sports medicine product launch
5th Sep 20237:00 amRNSInterim results
31st Aug 20231:45 pmRNSExercise of Options and Total Voting Rights
21st Aug 20237:00 amRNSNotice of interim results
17th Jul 20237:00 amRNSHalf-Year Trading Update
10th Jul 20237:00 amRNSDistribution agreement for OrthoPure® XT in the UK
25th May 20237:00 amRNSDistribution agreement with Australian Allografts
9th May 202312:00 pmRNSHolding(s) in Company
27th Apr 202312:35 pmRNSResult of AGM, Share Reorganisation &TVR
18th Apr 20237:00 amRNSProposed Share Reorganisation Timetable
5th Apr 20232:55 pmEQSHardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
5th Apr 20237:00 amRNSCEO and CFO Share Purchases
30th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
6th Mar 20237:00 amRNSNotice of results and Investor presentation
31st Jan 20237:01 amRNSTrading update for 2022
31st Jan 20237:00 amRNSChange of Adviser
18th Jan 202310:06 amRNSHolding(s) in Company
18th Jan 20237:00 amRNSChinese distribution agreement for OrthoPure® XT
7th Dec 20227:00 amRNSProduct launch in dCELL® division

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.